Quest Diagnostics Incorporated (DGX) स्टॉक विश्लेषण

कंपनी का अवलोकन

Quest Diagnostics Incorporated operates within the healthcare sector, specifically focusing on the diagnostics and research industry, where it delivers essential clinical testing services to medical professionals and laboratories across the United States. The organization's core business involves developing and providing a comprehensive suite of diagnostic information services, encompassing routine and non-routine clinical tests, advanced pathology analysis, and specialized diagnostic data solutions that support patient care and disease management. This entity maintains a significant operational footprint, employing approximately 46,000 individuals to support its extensive network of testing facilities and research capabilities. With a market capitalization of $21.90 billion and total revenue reaching $11.03 billion over the trailing twelve months, the company demonstrates substantial scale indicative of a major player in the diagnostic services landscape. These financial metrics suggest that Quest Diagnostics commands a dominant position capable of sustaining large-scale operations while serving a vast patient population, reflecting its established role as a critical infrastructure provider in the broader healthcare ecosystem.

वित्तीय स्वास्थ्य

The company reported revenue of $11.03 billion for the trailing twelve months, generating net income of $988.00 million and an EBITDA of $2.18 billion. The distinction between the total revenue and the net income reveals a cost structure where operating expenses, including cost of goods sold and administrative overhead, consume roughly 91% of the gross revenue before interest and taxes. Free cash flow stands at $1.01 billion, which indicates a robust capacity to fund capital expenditures, service debt obligations, or return capital to shareholders without compromising operational liquidity. The gross margin is recorded at 33.3%, reflecting the efficiency of converting raw materials and tests into revenue before overhead costs. Operating margin sits at 14.0%, showing the portion of revenue left after covering all direct and indirect operating expenses. Profit margin is calculated at 9.0%, representing the final percentage of revenue that translates into net earnings available to equity holders. On the balance sheet, total cash holdings of $420.00 million are compared against total debt of $6.58 billion, resulting in a debt-to-equity ratio of 90.38. This leverage profile indicates that the company utilizes financial debt to finance its growth, suggesting a leveraged rather than conservative balance sheet strategy. The current ratio is 1.04, which implies that the company holds slightly more current assets than current liabilities, maintaining a tight but adequate short-term liquidity position to meet immediate obligations. Return on equity is 14.8%, while return on assets is 6.2%, metrics that collectively reveal management's effectiveness in generating profits from both shareholder investments and the total asset base.

मूल्यांकन आकलन

The stock carries a trailing P/E ratio of 22.63 and a forward P/E of 17.23. The variance between these two figures implies that the market expects earnings growth in the future that would lower the P/E multiple over time, as the forward valuation is priced in at a discount relative to historical earnings. The price-to-book ratio is 3.03, indicating that the market values the company at a significant premium over its net asset book value, reflecting intangible assets like intellectual property and brand reputation. Alternative valuation metrics show a price-to-sales ratio of 1.98 and an EV/EBITDA of 12.88, suggesting that investors are willing to pay nearly twice the annual sales revenue for the company's earnings power. The stock's 52-week trading range spans from a low of $157.20 to a high of $213.50. Without a specific current share price provided in the source data, the exact percentage distance from the high or low cannot be calculated, but the range establishes the historical volatility envelope within which the stock has traded. The beta value is 0.65, which signifies that the stock price tends to be less volatile than the broader market, moving with lower amplitude relative to market swings.

Growth & Income

Revenue growth year-over-year is recorded at 7.1%, while earnings growth year-over-year stands at 11.0%. Since earnings are growing at a faster rate than revenue, this implies that the company is successfully improving its profitability margins or benefiting from operational efficiencies that outpace top-line expansion. For this dividend payer, the dividend yield is 1.7% with a payout ratio of 36.0%. A payout ratio of 36.0% is generally considered sustainable given the current earnings generation, as it retains the majority of profits for reinvestment while still providing a steady income stream to shareholders. The company does not fall into the non-dividend payer category; instead, it balances income distribution with internal capital needs. Overall, the growth and income profile presents a combination of moderate top-line expansion, accelerating earnings growth, and a consistent, sustainable dividend yield that supports long-term investor income objectives.